25 April 2023 - During a 1-year learning period, CADTH expanded its Scientific Advice program to include advice on real-world evidence (RWE), allowing applications after lockdown of protocols for pivotal trials.
Based on the positive experience and considerable interest from industry, CADTH is formalising this offering to enhance early engagement opportunities for pharmaceutical companies regarding RWE.